FDA Drug · D-0208-2025

Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.

Class III · Completed

Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet

Affected lots / codes — check yours against thisLot #: 2402101UR, Exp 02/28/2027

Recalling firm: Appco Pharma LLC, Piscataway, NJ
Classification: Class III (unlikely to cause harm)
Status: Completed
Quantity: 1380 bottles
Distribution: Nationwide USA.
Recall initiated: January 16, 2025
Classified: January 23, 2025
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0208-2025%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →